ADNI data is made available to researchers around the world. As such, there are many active research projects accessing and applying the shared ADNI data. To further encourage Alzheimer’s disease research collaboration, and to help prevent duplicate efforts, the list below shows the specific research focus of the active ADNI investigations. This information is requested annually as a requirement for data access.
|Principal Investigator's Name:||Adam Schwarz|
|Institution:||Eli Lilly and Company|
|Department:||Tailored Therapeutics (Imaging)|
|Proposed Analysis:||Examination of data to help planning the incorporation of imaging biomarkers in clinical trials.|